Newer drugs for the treatment of lupus nephritisKUIPER-GEERTSMA, Dudy G; DERKSEN, Ronald H. W. M.Drugs (Basel). 2003, Vol 63, Num 2, pp 167-180, issn 0012-6667, 14 p.Article

Tests for lupus anticoagulant revisitedDERKSEN, Ronald H. W. M; DE GROOT, Philip G.Thrombosis research. 2004, Vol 114, Num 5-6, pp 521-526, issn 0049-3848, 6 p.Conference Paper

Management of the obstetric antiphospholipid syndromeDERKSEN, Ronald H. W. M; KHAMASHTA, Munther A; BRANCH, D. Ware et al.Arthritis and rheumatism. 2004, Vol 50, Num 4, pp 1028-1039, issn 0004-3591, 12 p.Article

Igg antibodies that recognize epitope Gly40-Arg43 in domain I of β2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosisDE LAAT, Bas; DERKSEN, Ronald H. W. M; URBANUS, Rolf T et al.Blood. 2005, Vol 105, Num 4, pp 1540-1545, issn 0006-4971, 6 p.Article

Antiphospholipid antibodies: update on detection, pathophysiology, and treatmentDE GROOT, Philip G; DERKSEN, Ronald H. W. M.Current opinion in hematology. 2004, Vol 11, Num 3, pp 165-169, issn 1065-6251, 5 p.Article

Optimisation of lupus anticoagulant tests: should test samples always be mixed with normal plasma?PENNINGS, Maarten T. T; DE GROOT, Philip G; MEIJERS, Joost C. M et al.Thrombosis and haemostasis. 2014, Vol 112, Num 4, pp 736-742, issn 0340-6245, 7 p.Article

Twenty-two Years of Failure to Set Up Undisputed Assays to Detect Patients with the Antiphospholipid SyndromeDE GROOT, Philip G; DERKSEN, Ronald H. W. M; DE LAAT, Bas et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, Num 4, pp 347-355, issn 0094-6176, 9 p.Article

Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patientsCERVERA, Ricard; PIETTE, Jean-Charles; GALEAZZI, Mauro et al.Arthritis and rheumatism. 2002, Vol 46, Num 4, pp 1019-1027, issn 0004-3591Article

Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndromeROMAY-PENABAD, Zurina; AGUILAR-VALENZUELA, Renan; PIERANGELI, Silvia S et al.Blood. 2011, Vol 117, Num 4, pp 1408-1414, issn 0006-4971, 7 p.Article

Fcy receptor polymorphisms in systemic lupus erythematosus : Association with disease and in vivo clearance of immune complexesDIJSTELBLOEM, Hilde M; BIJL, Marc; KALLENBERG, Cees G. M et al.Arthritis and rheumatism. 2000, Vol 43, Num 12, pp 2793-2800, issn 0004-3591Conference Paper

Lupus anticoagulant in cardiovascular diseases : the role of β₂-glycoprotein IDE GROOT, Philip G; BOUMA, Barend; LUTTERS, Bianca C. H et al.Annals of medicine (Helsinki). 2000, Vol 32, pp 32-36, issn 0785-3890, SUP1Conference Paper

Premature atherosclerotic cardiovascular disease in systemic lupus erythematosusWESTERWEEL, Peter E; LUYTEN, Remco K. M. A. C; KOOMANS, Hein A et al.Arthritis and rheumatism. 2007, Vol 56, Num 5, pp 1384-1396, issn 0004-3591, 13 p.Article

Low levels of activated protein C in patients with systemic lupus erythematosus do not relate to lupus anticoagulants but to low levels of factor IISIMMELINK, Marleen J. A; FERNANDEZ, José A; DERKSEN, Ronald H. W. M et al.British journal of haematology. 2002, Vol 117, Num 3, pp 676-684, issn 0007-1048Article

β₂-Glycoprotein I, the playmaker of the antiphospholipid syndromeBAS DE LAAT, H; DERKSEN, Ronald H. W. M; DE GROOT, Philip G et al.Clinical immunology (Orlando, Fla. Print). 2004, Vol 112, Num 2, pp 161-168, issn 1521-6616, 8 p.Article

Oral anticoagulation reduces activated protein C less than protein C and other vitamin K-dependent clotting factorsSIMMELINK, Marleen J. A; DE GROOT, Philip G; DERKSEN, Ronald H. W. M et al.Blood. 2002, Vol 100, Num 12, pp 4232-4233, issn 0006-4971, 2 p.Article

Pathogenic anti-β₂-glycoprotein I antibodies recognize domain I of β₂-glycoprotein I only after a conformational changeDE LAAT, Bas; DERKSEN, Ronald H. W. M; VAN LUMMEL, Menno et al.Blood. 2006, Vol 107, Num 5, pp 1916-1924, issn 0006-4971, 9 p.Article

β₂-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndromeBAS DE LAAT, H; DERKSEN, Ronald H. W. M; URBANUS, Rolf T et al.Blood. 2004, Vol 104, Num 12, pp 3598-3602, issn 0006-4971, 5 p.Article

Correlation between antiphospholipid antibodies that recognize domain I of β2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5DE LAAT, Bas; WU, Xiao-Xuan; VAN LUMMEL, Menno et al.Blood. 2007, Vol 109, Num 4, pp 1490-1494, issn 0006-4971, 5 p.Article

β2-Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndromeAGAR, Cetin; VAN OS, Gwendolyn M. A; MÖRGELIN, Matthias et al.Blood. 2010, Vol 116, Num 8, pp 1336-1343, issn 0006-4971, 8 p.Article

A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/ methylprednisoloneGROOTSCHOLTEN, Cecile; DIEKER, Jürgen W. C; MCGRATH, Fabian D et al.Annals of the rheumatic diseases. 2007, Vol 66, Num 5, pp 693-696, issn 0003-4967, 4 p.Article

Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritisGROOTSCHOLTEN, Cecile; BAJEMA, Ingeborg M; BERDEN, Jo H. M et al.Arthritis and rheumatism. 2007, Vol 56, Num 3, pp 924-937, issn 0004-3591, 14 p.Article

Cortisol During the Day in Patients with Systemic Lupus Erythematosus or Primary Sjögren's SyndromeVAN DER GOES, Marlies C; BOSSEMA, Ercolie R; HARTKAMP, André et al.Journal of rheumatology. 2011, Vol 38, Num 2, pp 285-288, issn 0315-162X, 4 p.Article

Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older menDE LAAT, Bas; DE GROOT, Philip G; DERKSEN, Ronald H. W. M et al.Blood. 2009, Vol 114, Num 17, pp 3656-3661, issn 0006-4971, 6 p.Article

The antibacterial activity of peptides derived from human beta-2 glycoprotein I is inhibited by protein H and M1 protein from Streptococcus pyogenesNILSON, Maria; WASYLIK, Sylvie; MORGELIN, Mathias et al.Molecular microbiology (Print). 2008, Vol 67, Num 3, pp 482-492, issn 0950-382X, 11 p.Article

Lack of Association of C-C Chemokine Receptor 5 Δ32 Deletion Status with Rheumatoid Arthritis, Systemic Lupus Erythematosus, Lupus Nephritis, and Disease SeverityMARTENS, Henk A; GROSS, Sacha; KALLENBERG, Cees G. M et al.Journal of rheumatology. 2010, Vol 37, Num 11, pp 2226-2231, issn 0315-162X, 6 p.Article